Literature DB >> 18539710

Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.

H Abdel-Aty1, N Siegle, A Natusch, E Gromnica-Ihle, R Wassmuth, R Dietz, J Schulz-Menger.   

Abstract

Systemic lupus erythematosus (SLE) is a multi-organ inflammatory disorder mainly affecting women and is associated with high cardiovascular morbidity and mortality. We tested the utility of a comprehensive cardiovascular magnetic resonance approach to assess myocardial involvement and to determine its relation to disease activity in SLE patients. We studied 20 SLE patients (19 females, 35+/-10 years) and 13 healthy volunteers (nine females, 28+/-11 years). Classification followed the criteria of the American College of Rheumatology and assessment of SLE activity was based on the European Consensus Lupus Activity Measurement index. Cardiovascular magnetic resonance (CMR) was performed on a 1.5T scanner and included the following sequences: steady-state free precession, T2-weighted, early and late T1-weighted after gadolinium-DTPA injection. Ejection fraction was not significantly different between groups (controls: 63+/-6, inactive SLE: 67+/-7, active SLE 64+/-8; P=0.003 for all groups). In contrast, relative T2 ratio (myocardium to skeletal muscle) was significantly higher in active SLE than in the other groups (controls: 1.7+/-0.3, inactive: 1.8+/-0.2, active: 2.1+/-0.2; P=0.003). Similarly, early enhancement ratio was significantly higher in active SLE (controls: 2.4+/-1.4, inactive: 2.8+/-1.1, active: 4.5+/-2.0, P=0.39). Both relative T2 and early enhancement ratios significantly correlated with disease activity. Intramural foci of late enhancement were observed in three of eight patients (all with active SLE). Of the five patients with no late enhancement, only one had active disease. An imaging approach combining T2-weighted, early and late enhancement imaging is a useful tool to assess possible myocardial involvement in SLE. CMR parameters of global myocardial involvement correlate well with disease activity, but not with usual clinical signs as summarized in a cardiac score.

Entities:  

Mesh:

Year:  2008        PMID: 18539710     DOI: 10.1177/0961203308089401

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

Review 1.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

2.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

3.  Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.

Authors:  Tatsuya Nishii; Atsushi K Kono; Mayumi Shigeru; Sachiko Takamine; Sei Fujiwara; Katsusuke Kyotani; Nobukazu Aoyama; Kazuro Sugimura
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-09       Impact factor: 2.357

4.  Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.

Authors:  Yan Zhang; Celia P Corona-Villalobos; Adnan N Kiani; John Eng; Ihab R Kamel; Stefan L Zimmerman; Michelle Petri
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-29       Impact factor: 2.357

5.  Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study.

Authors:  Hany M Abo-Haded; Tarik S Barakat; Mona M Hafez
Journal:  Eur J Pediatr       Date:  2013-06-29       Impact factor: 3.183

Review 6.  Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.

Authors:  Amit R Patel; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2017-10

7.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study.

Authors:  Yasuyuki Kobayashi; Jon T Giles; Masaharu Hirano; Isamu Yokoe; Yasuo Nakajima; Joan M Bathon; Joao A C Lima; Hitomi Kobayashi
Journal:  Arthritis Res Ther       Date:  2010-09-13       Impact factor: 5.156

Review 8.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases.

Authors:  Jakub Lagan; Matthias Schmitt; Christopher A Miller
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-27       Impact factor: 2.357

9.  The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.

Authors:  Thilo Burkard; Marten Trendelenburg; Thomas Daikeler; Christoph Hess; Jens Bremerich; Philip Haaf; Peter Buser; Michael J Zellweger
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

10.  Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.

Authors:  Masahiro Hosonuma; Nobuyuki Yajima; Ryo Takahashi; Ryo Yanai; Taka-Aki Matsuyama; Eiji Toyosaki; Jumpei Saito; Kengo Kusano; Hiroshi Morita
Journal:  PLoS One       Date:  2020-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.